Champions Oncology, Inc. (NASDAQ: CSBR) Starts Presentation at LD Micro Main Event
Champions Oncology (NASDAQ: CSBR) is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune-deficient mice to create TumorGrafts that preserve the biological characteristics of the original human tumor to determine the efficacy of a treatment regimen. The company uses this technology in conjunction with related services to offer solutions for two customer groups: Personalized Oncology Solutions and Translational Oncology Solutions. For more information, visit the company’s website at…







